{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:49:17Z","timestamp":1795063757722,"version":"4.10.2"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cerebral cavernous malformations (CCMs) are pathologic lesions comprised of clusters of thin-walled capillaries characterized by abnormal proliferation, angiogenesis, and bleeding secondary to somatic or germline mutations in endothelial cells. CCMs can cause headaches, seizures and\/or neurological defects. There is a clinical need to develop better tools to detect CCMs and follow their progression in conjunction with the current use of neuroimaging techniques. Here we present data supporting the utility of LOX-1 (lectin-type oxidized LDL receptor 1), a 50\u2009kDa transmembrane protein implicated in endothelial cell dysfunction and ischemia, as a putative biomarker for CCM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>CCM urine samples (<jats:italic>n<\/jats:italic>\u2009=\u200923) were collected from pediatric CCM patients. Matched healthy controls (<jats:italic>n\u2009=<\/jats:italic> 24) were collected from pediatric patients with either Chiari I malformation or fatty filum terminale, and otherwise normal findings. All samples were collected with patient\/family consent and institutional review board approval.<\/jats:p><jats:p>Samples were analyzed with Olink Proteomic Proximity Extension Assay (PEA). Differences in expression for 2,925 unique proteins were quantified between healthy control urine samples and CCM urine samples. The results were normalized, validated, and analyzed for demographic bias. In addition to urine samples, CCM tissue from patients was harvested and used to create primary cell lines for <jats:italic>in vitro<\/jats:italic> analysis of LOX-1 expression, in addition to immunofluorescence of lesional tissue excised at surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>ANOVA analysis of the CCM urine samples showed a statistically significant increase in LOX-1 compared to the control samples, with CCM patients exhibiting a\u2009&amp;gt;\u20095-fold increase in urinary expression. Corroborating these elevated levels of circulating marker, analysis of source tissue from surgically resected CCMs revealed that LOX-1 is increased in both CCM patient cavernoma primary cell lines and operative specimens.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>LOX-1 is involved with pathways implicated in CCM pathogenesis and our data here reveals that LOX-1 expression is significantly elevated in CCM patients as compared to matched healthy control individuals, including both source tissue from surgically excised CCMs and in analysis of samples collected from outside of the central nervous system, particularly urine. This proof-of-principle data suggests that LOX-1 may have potential utility as a target for CCM treatment and supports further investigation related to its potential mechanistic impact on CCM pathogenesis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2024.1442110","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:18:18Z","timestamp":1724343498000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment"],"prefix":"10.3389","volume":"18","author":[{"given":"Karthik","family":"Ashok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyra","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Sesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Nasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Shan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Heuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Alejandro","family":"Lopez-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram","family":"Ghalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1158\/0008-5472.CAN-13-3116","article-title":"Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma","volume":"74","author":"Akino","year":"2014","journal-title":"Cancer Res."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2017.11.014","article-title":"KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for cerebral cavernous malformation disease","volume":"115","author":"Antognelli","year":"","journal-title":"Free Radic. Biol. Med."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.dib.2017.12.026","article-title":"Data in support of sustained upregulation of adaptive redox homeostasis mechanisms caused by KRIT1 loss-of-function","volume":"16","author":"Antognelli","year":"","journal-title":"Data Brief"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1185021","DOI":"10.3389\/fnmol.2023.1185021","article-title":"Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder","volume":"16","author":"Bao","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1161\/ATVBAHA.120.315421","article-title":"The role of LOX-1 as a cardiovascular risk predictor: mechanistic insight and potential clinical use","volume":"41","author":"Barreto","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/neuonc\/noaa016","article-title":"A phase I\/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a pediatric brain tumor consortium study","volume":"22","author":"Baxter","year":"2020","journal-title":"Neuro-Oncology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"14643","DOI":"10.3390\/ijms232314643","article-title":"Distant recurrence of a cerebral cavernous malformation in the vicinity of a developmental venous anomaly: case report of local oxy-inflammatory events","volume":"23","author":"Bianconi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"889647","DOI":"10.3389\/fneur.2022.889647","article-title":"Technical performance evaluation of Olink proximity extension assay for blood-based biomarker discovery in longitudinal studies of Alzheimer\u2019s disease","volume":"13","author":"Carlyle","year":"2022","journal-title":"Front. Neurol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0163-7258(02)00236-x","article-title":"LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis","volume":"95","author":"Chen","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"22607","DOI":"10.1038\/srep22607","article-title":"MiR-590-5p inhibits oxidized- LDL induced angiogenesis by targeting LOX-1","volume":"6","author":"Dai","year":"2016","journal-title":"Sci. Rep."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.nec.2022.05.001","article-title":"Cavernous malformations: updates in surgical management and biology","volume":"33","author":"Dammann","year":"2022","journal-title":"Neurosurg. Clin. N. Am."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3171\/jns.1997.87.4.0629","article-title":"De novo formation of a central nervous system cavernous malformation: implications for predicting risk of hemorrhage: case report and review of the literature","volume":"87","author":"Detwiler","year":"1997","journal-title":"J. Neurosurg."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"19244","DOI":"10.1038\/s41598-023-46763-z","article-title":"Disease specific urinary biomarkers in the central nervous system","volume":"13","author":"Duggins-Warf","year":"2023","journal-title":"Sci. Rep."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s12276-020-0414-0","article-title":"Dysregulation of the EphrinB2\u2212EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients","volume":"52","author":"Fehnel","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2013.11.020","article-title":"KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun","volume":"68","author":"Goitre","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"8296","DOI":"10.1038\/s41598-017-08373-4","article-title":"Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium","volume":"7","author":"Goitre","year":"2017","journal-title":"Sci. Rep."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3171\/2022.12.PEDS22332","article-title":"Increasing precision in the management of pediatric neurosurgical cerebrovascular diseases with molecular genetics","volume":"31","author":"Kahle","year":"2023","journal-title":"J. Neurosurg. Pediatr."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.gendis.2023.02.045","article-title":"Identification of galectin-3 as a novel potential prognostic\/predictive biomarker and therapeutic target for cerebral cavernous malformation disease","volume":"11","author":"Kar","year":"2024","journal-title":"Genes Dis."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/antiox8070218","article-title":"LOX-1: Regulation, signaling and its role in atherosclerosis","volume":"8","author":"Kattoor","year":"2019","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/jon.13072","article-title":"Cerebral cavernous malformations: typical and atypical imaging characteristics","volume":"33","author":"Kuroedov","year":"2023","journal-title":"J. Neuroimag.: Official J. American Society of Neuroimag."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.122.321129","article-title":"Neuroinflammation plays a critical role in cerebral cavernous malformation disease","volume":"131","author":"Lai","year":"2022","journal-title":"Circ. Res."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"101002","DOI":"10.1016\/j.spen.2022.101002","article-title":"Pediatric Moyamoya biomarkers: narrowing the knowledge gap","volume":"43","author":"Lehman","year":"2022","journal-title":"Semin. Pediatr. Neurol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"103165","DOI":"10.1016\/j.jaut.2023.103165","article-title":"Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis","volume":"143","author":"Li","year":"2024","journal-title":"J. Autoimmun."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/s0735-1097(02)02966-2","article-title":"Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction","volume":"41","author":"Li","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.15252\/emmm.201505316","article-title":"Defective autophagy is a key feature of cerebral cavernous malformations","volume":"7","author":"Marchi","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"594441","DOI":"10.3389\/fcvm.2020.594441","article-title":"Proteolytic regulation of the lectin-like oxidized lipoprotein receptor LOX-1","volume":"7","author":"Mentrup","year":"2020","journal-title":"Front. Cardiovascular Med."},{"key":"ref27","first-page":"128","article-title":"131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies","volume":"35","author":"Otten","year":"1989","journal-title":"Neuro-Chirurgie"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/tox.22750","article-title":"Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway","volume":"34","author":"Ou","year":"2019","journal-title":"Environ. Toxicol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e13164","DOI":"10.1111\/bpa.13164","article-title":"Monomeric C-reactive protein: a novel biomarker predicting neurodegenerative disease and vascular dysfunction","volume":"33","author":"Pastorello","year":"2023","journal-title":"Brain Pathology (Zurich, Switzerland)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ajog.2023.08.007","article-title":"The association between human chorionic gonadotropin and adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"230","author":"Peris","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1089\/ars.2021.0263","article-title":"KRIT1: a traffic Warden at the busy crossroads between redox signaling and the pathogenesis of cerebral cavernous malformation disease","volume":"38","author":"Perrelli","year":"2023","journal-title":"Antioxid. Redox Signal."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.freeradbiomed.2021.06.021","article-title":"Polymorphisms in genes related to oxidative stress and inflammation: emerging links with the pathogenesis and severity of cerebral cavernous malformation disease","volume":"172","author":"Perrelli","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"152786","DOI":"10.1155\/2013\/152786","article-title":"LOX-1, OxLDL, and atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3171\/2015.12.PEDS15448","article-title":"Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature","volume":"18","author":"Pricola Fehnel","year":"2016","journal-title":"J. Neurosurg. Pediatr."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3171\/2020.2.PEDS19543","article-title":"Recurrence of cavernous malformations after surgery in childhood","volume":"26","author":"Prolo","year":"2020","journal-title":"J. Neurosurg. Pediatr."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.biocel.2016.09.011","article-title":"Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: two sides of the same coin","volume":"81","author":"Retta","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/jmg.2006.041079","article-title":"Cerebral cavernous malformation: new molecular and clinical insights","volume":"43","author":"Revencu","year":"2006","journal-title":"J. Med. Genet."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s11547-018-0896-1","article-title":"Is MRI imaging in pediatric age totally safe? A critical reprisal","volume":"123","author":"Salerno","year":"2018","journal-title":"Radiol. Med."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3390\/biomedicines11041051","article-title":"Urinary biomarkers and point-of-care urinalysis devices for early diagnosis and Management of Disease: a review","volume":"11","author":"Sequeira-Antunes","year":"2023","journal-title":"Biomedicine"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.661952","article-title":"Non-invasive urinary biomarkers in Moyamoya disease","volume":"12","author":"Sesen","year":"","journal-title":"Front. Neurol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"147348","DOI":"10.1016\/j.brainres.2021.147348","article-title":"Neogenin is highly expressed in diffuse intrinsic pontine glioma and influences tumor invasion","volume":"1762","author":"Sesen","year":"","journal-title":"Brain Res."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.3390\/ijms20194930","article-title":"KRIT1 deficiency promotes aortic endothelial dysfunction","volume":"20","author":"Sesen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s10571-023-01447-0","article-title":"Discovery and characterization of Ephrin B2 and EphB4 dysregulation and novel mutations in cerebral cavernous malformations: in vitro and patient-derived evidence of Ephrin-mediated endothelial cell pathophysiology","volume":"44","author":"Sesen","year":"2024","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3340\/jkns.2015.57.6.415","article-title":"Moyamoya Biomarkers","volume":"57","author":"Smith","year":"2015","journal-title":"J. Korean Neurosurgical Society"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMra2305116","article-title":"Cavernous malformations of the central nervous system","volume":"390","author":"Smith","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.nec.2010.03.003","article-title":"Cavernous malformations","volume":"21","author":"Smith","year":"2010","journal-title":"Neurosurg. Clin. N. Am."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/1078-0432.CCR-07-1253","article-title":"Urinary biomarkers predict brain tumor presence and response to therapy","volume":"14","author":"Smith","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.clineuro.2012.06.023","article-title":"Ultrastructural analysis of vascular features in cerebral cavernous malformations","volume":"115","author":"Tanriover","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-0716-0640-7_4","article-title":"Molecular genetic screening of CCM patients: an overview","volume":"2152","author":"Tournier-Lasserve","year":"2020","journal-title":"Methods in Molecular Biology (Clifton, N.J.)"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s00018-012-1194-z","article-title":"LOX-1 in atherosclerosis: biological functions and pharmacological modifiers","volume":"70","author":"Xu","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1021\/acs.biochem.6b00469","article-title":"Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1): a chameleon receptor for oxidized LDL","volume":"55","author":"Zeya","year":"2016","journal-title":"Biochemistry"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1442110\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:18:23Z","timestamp":1724343503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1442110\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":51,"alternative-id":["10.3389\/fnins.2024.1442110"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2024.1442110","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fnins.2024.1442110.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fnins.2024.1442110.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fnins.2024.1442110.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fnins.2024.1442110.s004","asserted-by":"subject"}]},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"article-number":"1442110"}}